scholarly journals Comparison of Apatite-Wollastonite Glass-Ceramic and β-tricalcium Phosphate used as Bone Graft Substitutes after Curettage of Bone Cysts

Author(s):  
Pavel Sponer ◽  
Karel Urban ◽  
Tomas Kucer
2013 ◽  
Vol 472 (2) ◽  
pp. 767-768 ◽  
Author(s):  
Joerg Friesenbichler ◽  
Werner Maurer-Ertl ◽  
Patrick Sadoghi ◽  
Ulrike Pirker-Fruehauf ◽  
Koppany Bodo ◽  
...  

2012 ◽  
Vol 18 (23-24) ◽  
pp. 2426-2436 ◽  
Author(s):  
Asli Ergun ◽  
Xiaojun Yu ◽  
Antonio Valdevit ◽  
Arthur Ritter ◽  
Dilhan M. Kalyon

2021 ◽  
Vol 32 (2) ◽  
pp. 526-530
Author(s):  
Takuya Uemura ◽  
Koichi Yano ◽  
Kiyohito Takamatsu ◽  
Yusuke Miyashima ◽  
Hiroyuki Yasuda ◽  
...  

Romosozumab is a humanized, anti-sclerostin monoclonal antibody used to treat osteoporosis, which increases bone formation and decreases bone resorption. It enhances fracture healing and systemic romosozumab administration may have therapeutic potentials for accelerating bone healing of even nonunion. Herein, a 61-year-old heavy smoker male with distal radius nonunion who achieved successful bone union by combination therapy of romosozumab and spanning distraction plate fixation with bone graft substitutes was presented. Through the dorsal approach, atrophic comminuted nonunion of the distal radius was sufficiently debrided. Reduction of the distal radius was performed using indirect ligamentotaxis, and a 14-hole locking plate was fixed from the third metacarpal to the radial shaft. A beta (β) tricalcium phosphate block was mainly packed into the substantial metaphyseal bone defect with additional bone graft from the resected ulnar head. Postoperatively, systemic administration of monthly romosozumab was continued for six months. Complete bone union was achieved 20 weeks postoperatively and the plate was, then, removed. Wrist extension and flexion improved to 75o and 55o, respectively, without pain, and grip strength increased 52 weeks postoperatively from 5.5 kg to 22.4 kg. During romosozumab treatment, bone formation marker levels increased rapidly and finally returned to baseline, and bone resorption marker levels remained low. In conclusion, combination of systemic romosozumab administration and grafting β-tricalcium phosphate with bridge plating provides an effective treatment option for difficult cases of comminuted distal radius nonunion with risk factors such as smoking, diabetes, and fragility.


1990 ◽  
Vol 25 (2) ◽  
pp. 545
Author(s):  
Ik Dong Kim ◽  
Poong Taek Kim ◽  
Byung Chul Park ◽  
Young Wook Choi ◽  
Young Goo Lyu ◽  
...  

2013 ◽  
Vol 472 (3) ◽  
pp. 976-982 ◽  
Author(s):  
Joerg Friesenbichler ◽  
Werner Maurer-Ertl ◽  
Patrick Sadoghi ◽  
Ulrike Pirker-Fruehauf ◽  
Koppany Bodo ◽  
...  

1987 ◽  
Vol 18 (2) ◽  
pp. 323-334 ◽  
Author(s):  
Robert W. Bucholz ◽  
Ann Carlton ◽  
Ralph E. Holmes

Sign in / Sign up

Export Citation Format

Share Document